Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases is a research paper published in Advanced NanoBiomed Research (2023). On theSindex it has a DataRank of 0.542. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: K08-HL-138269-01
National Heart, Lung, and Blood Institute
Grant: R01-HL-153510-01
National Heart, Lung, and Blood Institute
Grant: R01-H-160694-01
National Center for Advancing Translational Sciences
Grant: KL2TR001879
Boehringer Ingelheim
Grant: Discovery Award
National Institutes of Health
Grant: 5KL2TR001879-04
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 5F31HL154662-03
Nanoscale drug carriers for the treatment of Acute Respiratory Distress Syndrome (ARDS).
National Institutes of Health
Grant: 5K08HL138269-02
Nanonscale drug carriers for the treatment of acute respiratory distress syndrome
National Institutes of Health
Grant: 5R01HL160694-02
Controlling complement to unleash nanomedicine for acute critical illnesses
National Institutes of Health
Grant: 5T32GM008076-12
PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGY
National Institutes of Health
Grant: 5R01HL153510-05
Nanomedicine for ARDS: A new paradigm to target drugs to multiple cell types within alveolar capillaries
Fields of Study
Keywords
Sustainable Development Goals